Hermans C, Dessomme B, Lambert C, Deneys V
Service d'hématologie et laboratoire d'hémostase, unité d'hémostase-thrombose, cliniques universitaires Saint-Luc, 10, avenue Hippocrate, 1200 Bruxelles, Belgique.
Ann Chir Plast Esthet. 2006 Aug-Oct;51(4-5):388-93. doi: 10.1016/j.anplas.2006.07.009. Epub 2006 Sep 26.
Activation of the coagulation process is frequently encountered in patients with venous vascular malformations and results in the local formation of clots and the consumption of components of the coagulation process (platelets, clotting factors). This activation accounts for multiple biological abnormalities such as the elevation of the D-dimers, reduction of fibrinogen and platelets count and less frequently a local intravascular coagulation (LIC). This process seems to be responsible for the local painful symptoms. In case of LIC, bleeding complications may be observed. Therapeutically, antithrombotic treatment with low-molecular weight heparin can improve the local coagulopathy with beneficial effects on blood tests disturbances, pain and bleeding tendency.
凝血过程的激活在静脉血管畸形患者中经常出现,会导致局部血栓形成以及凝血过程成分(血小板、凝血因子)的消耗。这种激活导致多种生物学异常,如D - 二聚体升高、纤维蛋白原和血小板计数降低,较少见的是局部血管内凝血(LIC)。该过程似乎是局部疼痛症状的原因。在发生LIC的情况下,可能会观察到出血并发症。在治疗上,使用低分子量肝素进行抗血栓治疗可改善局部凝血病,对血液检查异常、疼痛和出血倾向产生有益影响。